Project: A rapid diagnostic test to predict heart failure after a myocardial infarction

Acronym	HEARTLINC (Reference Number: 11020)
Duration	01/05/2017
Project Topic	The consortium will develop an innovative in vitro diagnostic (IVD) test to assess the risk of developing heart failure (HF) after acute myocardial infarction (AMI). The test is based on a unique profile of long noncoding RNAs (lncRNA). In this project, the medical benefit of the IVD test will be validated in blood samples of European and Asian AMI patients. The HEARTLINC project will deliver an IVD test suitable for fast, multiplex and high throughput HF prediction.
Network	Eurostars 2
Call	Eurostars Cut-Off 6

Project partner

Number	Name	Role	Country
1	Firalis SAS	Coordinator	France
2	QuantaMatrix Inc.	Partner	Korea, Republic of
3	SimplicityBio SA	Partner	Switzerland
4	Seoul National University Hospital	Partner	Korea, Republic of
5	Centre Hospitalier Universitaire de Toulouse	Partner	France